The federal Judicial Panel on Multidistrict Litigation sent the lawsuits to the Western District of Louisiana, in Lafayette, to be overseen by U.S. District Judge Rebecca Doherty. Doherty will coordinate pretrial proceedings, including evidence- gathering.Read More
Actos, or pioglitazone, is a drug given to patients suffering from type 2 diabetes. The drug falls in the same class of drugs as Avandia and was approved for use by the FDA in 1999.
Recent studies linking Actos to Bladder Cancer have resulted in warnings about the drug by the U.S. Food and Drug Administration and all-out bans by agencies in France and Germany. A French study examining more than 150,000 people on Actos found that those taking the drug had a greater risk of getting bladder cancer.
The recent news came as a shock to millions of diabetics who switched to Actos instead of Avandia after finding out that Avandia may cause heart attacks. Experts now worry that millions could be at risk of bladder cancer due to Actos and may not even know it.
According to the FDA warning issued in June, 2011, Actos may pose a risk of bladder cancer for anyone currently at risk for the disease or anyone taking the drug fro more than a year. Due to the failure of the drug maker to warn patients of these dangers, they are liable for the damages caused.
It is tragic when those who trust a medication to help with a disease are injured by an even more serious side effect. Fortunately, those affected by Actos have legal options to help with the treatment and recovery from bladder cancer.
If you or a loved one have developed bladder cancer after taking Actos, it is important to learn your legal rights. You may be entitled to a substantial recovery, however, the time to take action is limited.
|Actos||Side Effects||Bladder Cancer|
|Health Risks||Local Help||Legal Options|
Japanese drugmaker Takeda Pharmaceuticals announced this month that profit forecasts for the year would be down nearly 32 percent from last year, when they enjoyed success with the most popular diabetes drug in the world.
The company attributed the losses to the recent $13.3 billion purchase of Swiss drugmaker Nycomed in September, as well as the declining value of the U.S. dollar against the yen, however, drug analysts believe other factors are at play as well.Read More
An Edwardsville man claims he developed bladder cancer because drug manufacturers purposefully hid the risks of his diabetes medication.
William R. Greenlee and his wife, Diana, filed a complaint Jan. 4 in Madison County Circuit Court against Takeda Pharmaceuticals America Inc., Takeda Pharmaceuticals North America Inc., Takeda Pharmaceutical Company Limited and Eli Lilly and Company.
On June 15, 2011, the Food and Drug Administration warned consumers that taking the diabetes drug Actos for more than a year could be related to an increased risk of bladder cancer.
The warning followed the release of several studies in Europe showing the drug’s possible dangers, and an ongoing study in the United States which has produced concerning results so far.
The health risks of Actos are severe enough that both France and Germany have banned any further sales of the drug pending additional research. In the United States, however, where drug companies carry exceptional weight with lawmakers, Actos remains on the market.
Each year, approximately 70,000 people in the United States are diagnosed with bladder cancer. The disease attacks the lining of the bladder, spreading from there if not treated or removed. Other than Actos, tobacco use can be a major contributing factor to bladder cancer.
Due to the early onset of symptoms, most cases of bladder cancer are caught at early stages. Although highly treatable, patients will still need regular checkups to make sure no cancer cells were missed.
Takeda Pharmaceuticals, who manufactures the drug, made approximately $3.4 billion last year on selling Actos. They have declined to halt sales of the drug, arguing that it still carries positive results for many patients.
Lawyers have already helped thousands of those who developed bladder cancer after taking Actos file a claim. They expect at least 10,000 people will eventually come forward to seek legal help. However, there is only a limited amount of time to take action if you have been affected.
Contact us today for more help if you have been diagnosed with bladder cancer. We are available 24 hours a day for a confidential evaluation of your case.